Monotherapy with SGLT2 inhibitor or GLP-1 receptor agonist

Research studies on Monotherapy with SGLT2 inhibitor or GLP-1 receptor agonist - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.